Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats

HIGHLIGHTS

• who: Takuya Koizumi from the Chiba University, Japan have published the paper: Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats, in the Journal: (JOURNAL)
• what: The authors aimed to further investigate this, and examine whether the SGLT2-i empagliflozin suppresses mitochondrial-ROS generation and mitigates fibrosis. The authors tested the cardioprotective ability of empagliflozin against atrial remodeling and explored the underlying mechanisms associated with mitochondrial function in a murine frontiersin.org 10.3389/fcvm.2023.1005408 Western blotting analyses regarding mitochondrial biogenesis, fission, and fusion. Taken . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.